Raymond James Financial
WVE icon

Raymond James Financial’s Wave Life Sciences WVE Stock Holding History

Raymond James Financial’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,000
Closed -$50K – 5463
2025
Q4 		$50K Buy
+10,000
New +$102K ﹤0.01% 5008

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Raymond James Financial's WVE Position: Q1 2026 in Review

Raymond James Financial reduced its Wave Life Sciences (WVE) stake by 64% in Q1 2026, selling an estimated $932K and leaving 39,625 shares worth $287K. The position accounts for ﹤0.01% of the portfolio, ranked #4678.

Raymond James Financial first reported a position in WVE in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.89M in Q4 2025. 231 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Raymond James Financial held 39,625 shares of Wave Life Sciences worth $287K as of Q1 2026.
  • Raymond James Financial sold 71,545 Wave Life Sciences shares in Q1 2026, an estimated $932K.
  • Wave Life Sciences made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #4678 holding.
  • Raymond James Financial first reported a position in Wave Life Sciences in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Wave Life Sciences position peaked at $1.89M in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.